COVID-19 Vaccine Pharmacovigilance Dashboard



In May 2021, PAHO incorporated the Vaccine Pharmacovigilance Dashboard (developed to support regulatory efforts and the monitoring of vaccine safety) in the available resources related to COVID-19 vaccines.


This dashboard is presented in Spanish and English, and consists of the following components or sections:

  • Number of vaccines in the various phases of clinical evaluation, as well as vaccines included in the WHO Emergency Use Listing (EUL) and authorized by countries or regions;
  • Information on each of the authorized vaccines, including: authorization, manufacture, general characteristics, dosage and administration schedule, indications and contraindications, storage and logistics, clinical studies and efficacy, pre- and postauthorization safety, monitoring, and references. This information is presented in layers, allowing for sequential access to the content developed.
  • Resources: including the Regional vaccination dashboard and the WHO coronavirus dashboard; collection of manuals, guides, and documents on COVID-19 vaccines; regulation and related topics; available training; as well as consolidated regional and global information bulletins on adverse events following vaccination (AEFI) against COVID-19 and other updates issued to date;
  • Updated news and evidence;
  • Methods used in the pharmacovigilance dashboard for COVID-19 vaccines;
  • Glossary of terms.

The COVID-19 Vaccine Pharmacovigilance Dashboard is available at:   


  • Share: